|
1
|
Alexy T, Pais E, Wenby RB, Mack WJ, Hodis
HN, Kono N, Wang J, Baskurt OK, Fisher TC and Meiselman HJ:
Abnormal blood rheology and chronic low grade inflammation:
Possible risk factors for accelerated atherosclerosis and coronary
artery disease in Lewis negative subjects. Atherosclerosis.
239:248–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kucharska-Newton AM, Heiss G, Ni H,
Stearns SC, Puccinelli-Ortega N, Wruck LM and Chambless L:
Identification of heart failure events in medicare claims: The
atherosclerosis risk in communities (ARIC) study. J Card Fail.
22:48–55. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Naghavi M, Libby P, Falk E, Casscells SW,
Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P,
Pasterkamp G, et al: From vulnerable plaque to vulnerable patient:
A call for new definitions and risk assessment strategies: Part I.
Circulation. 108:1664–1672. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang XI, Luo Y, Zhao S, Chen Q, Jiang C,
Dai Y, Chen Y and Cao Z: Clinical significance and expression of
microRNA in diabetic patients with erectile dysfunction. Exp Ther
Med. 10:213–218. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jia W, Wu Y, Zhang Q, Gao GE, Zhang C and
Xiang Y: Expression profile of circulating microRNAs as a promising
fingerprint for cervical cancer diagnosis and monitoring. Mol Clin
Oncol. 3:851–858. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Graziano A, Lo Monte G, Piva I, Caserta D,
Karner M, Engl B and Marci R: Diagnostic findings in adenomyosis: A
pictorial review on the major concerns. Eur Rev Med Pharmacol Sci.
19:1146–1154. 2015.PubMed/NCBI
|
|
7
|
Tang Y, Zhang YC, Chen Y, Xiang Y, Shen CX
and Li YG: The role of miR-19b in the inhibition of endothelial
cell apoptosis and its relationship with coronary artery disease.
Sci Rep. 5:151322015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ouimet M, Ediriweera HN, Gundra UM, Sheedy
FJ, Ramkhelawon B, Hutchison SB, Rinehold K, van Solingen C,
Fullerton MD, Cecchini K, et al: MicroRNA-33-dependent regulation
of macrophage metabolism directs immune cell polarization in
atherosclerosis. J Clin Invest. 125:4334–4348. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ross R: The pathogenesis of
atherosclerosis-an update. N Engl J Med. 314:488–500. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ross R: Atherosclerosis-an inflammatory
disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oguz N, Kirca M, Cetin A and Yesilkaya A:
Effect of uric acid on inflammatory COX-2 and ROS pathways in
vascular smooth muscle cells. J Recept Signal Transduct Res.
37:500–505. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rumzhum NN and Ammit AJ: Cyclooxygenase 2:
Its regulation, role and impact in airway inflammation. Clin Exp
Allergy. 46:397–410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schonbeck U, Sukhova GK, Graber P, Coulter
S and Libby P: Augmented expression of cyclooxygenase-2 in human
atherosclerotic lesions. Am J Pathol. 155:1281–1291. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baker CS, Hall RJ, Evans TJ, Pomerance A,
Maclouf J, Creminon C, Yacoub MH and Polak JM: Cyclooxygenase-2 is
widely expressed in atherosclerotic lesions affecting native and
transplanted human coronary arteries and colocalizes with inducible
nitric oxide synthase and nitrotyrosine particularly in
macrophages. Arterioscler Thromb Vasc Biol. 19:646–655. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dursunoglu N, Dursunoglu D, Yildiz AI,
Uludag B, Alaçam ZN and Sarıçopur A: Severity of coronary
atherosclerosis in patients with COPD. Clin Respir J. 11:751–756.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alhouayek M and Muccioli GG: COX-2-derived
endocannabinoid metabolites as novel inflammatory mediators. Trends
Pharmacol Sci. 35:284–292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Motino O, Agra N, Contreras Brea R,
Domínguez-Moreno M, García-Monzón C, Vargas-Castrillón J, Carnovale
CE, Boscá L, Casado M, Mayoral R, et al: Cyclooxygenase-2
expression in hepatocytes attenuates non-alcoholic steatohepatitis
and liver fibrosis in mice. Biochim Biophys Acta. 1862:1710–1723.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim HJ, Yim GW, Nam EJ and Kim YT:
Synergistic effect of COX-2 inhibitor on paclitaxel-induced
apoptosis in the human ovarian cancer cell line OVCAR-3. Cancer Res
Treat. 46:81–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ross S, Eikelboom J, Anand SS, Eriksson N,
Gerstein HC, Mehta S, Connolly SJ, Rose L, Ridker PM, Wallentin L,
et al: Association of cyclooxygenase-2 genetic variant with
cardiovascular disease. Eur Heart J. 35:2242–2248a. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
More AS, Kim HM, Zhao R, Khang G,
Hildebrandt T, Bernlöhr C, Doods H, Lee D, Lee SH, Vanhoutte PM and
Wu D: COX-2 mediated induction of endothelium-independent
contraction to bradykinin in endotoxin-treated porcine coronary
artery. J Cardiovasc Pharmacol. 64:209–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Papageorgiou N, Zacharia E, Briasoulis A,
Charakida M and Tousoulis D: Celecoxib for the treatment of
atherosclerosis. Expert Opin Investig Drugs. 25:619–633. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu D, Wang D, Xu Z, Gao J, Liu M, Liu Y,
Jiang M and Zheng D: Dysregulated expression of miR-101b and
miR-26b lead to age-associated increase in LPS-induced COX-2
expression in murine macrophage. Age (Dordr). 37:972015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang Y, Zhao Q, Fan L, Zhang Z, Tan B,
Liu Y and Li Y: Down-regulation of MicroRNA-381 promotes cell
proliferation and invasion in colon cancer through up-regulation of
LRH-1. Biomed Pharmacother. 75:137–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liang HQ, Wang RJ, Diao CF, Li JW, Su JL
and Zhang S: The PTTG1-targeting miRNAs miR-329, miR-300, miR-381
and miR-655 inhibit pituitary tumor cell tumorigenesis and are
involved in a p53/PTTG1 regulation feedback loop. Oncotarget.
6:29413–29427. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Y, Ohms SJ, Li Z, Wang Q, Gong G, Hu Y,
Mao Z, Shannon MF and Fan JY: Changes in the expression of miR-381
and miR-495 are inversely associated with the expression of the
MDR1 gene and development of multi-drug resistance. PLoS One.
8:e820622013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen B, Duan L, Yin G, Tan J and Jiang X:
Simultaneously expressed miR-424 and miR-381 synergistically
suppress the proliferation and survival of renal cancer cells-Cdc2
activity is up-regulated by targeting WEE1. Clinics (Sao Paulo).
68:825–833. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rothschild SI, Tschan MP, Jaggi R, Fey MF,
Gugger M and Gautschi O: MicroRNA-381 represses ID1 and is
deregulated in lung adenocarcinoma. J Thorac Oncol. 7:1069–1077.
2012. View Article : Google Scholar : PubMed/NCBI
|
